Find the latest pharmaceutical market place for formulations enquiry about Sevelamer Hydrochloride on PharmaCompass.com.

Sevelamer (800 mg) Tablets needed in Israel [ENA18720]

A company that focuses on distribution of wide range of pharmaceutical products including licensed products, unlicensed products, and APIs for the Israeli and Palestinian markets is looking for Sevelamer (800 mg) Tablets for commercial purposes. The required quantity is 9,00,000 units.

Reply

04 Dec 2023

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA16886]

General hospital for active treatment "National Cardiology Hospital" EAD is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 3-May-2023.
1. Calcitriol (0.25 mg) Tablets. The required quantity is 25,000 units.
2. Sevelamer (800 mg) Tablets. The required quantity is 36,000 units.

Reply

14 Apr 2023

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA16177]

Mnogoprofilna Bolnitsa Za Aktivno Lechenie - Samokov Eood is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 15-Feb-2023.
1. Meropenem (1 g) Injections. The required quantity is 198,000 units.
2. Levofloxacin (5 mg/ ml in 100 ml) Injections. The required quantity is 88,800 units.
3. Sevelamer (800 mg) Tablets. The required quantity is 14,000 units.

Reply

23 Jan 2023

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA15480]

Spetsializirana bolnitsa za aktivno lechenie po detski bolesti – prof.Ivan Mitev EAD is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 1-Dec-2022.
1. Sevelamer (800 mg) Film coated Tablets. The required quantity is 10,000 units.
2. Ceftriaxone (1 g) Powder for Solution for Injections. The required quantity is 8,000 units.
3. Methylprednisolone (40 mg) Powder and Solvent for Solution for Injections. The required quantity is 7,500 units.
4. Mycophenolic Acid (180 mg) Gastro-Resistant Tablets. The required quantity is 7,000 units.

Reply

05 Nov 2022

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA12512]

Mnogoprofilna Bolnitsa Za Aktivno Lechenie - Ivan Skenderov Eood is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 10-Feb-2022.
1. Azithromycin (500 mg) Tablets. The required quantity is 10,050 units.
2. Ceftriaxone (2 g) Powder for Injections. The required quantity is 30,000 units.
3. Bromhexine (8 mg) Tablets. The required quantity is 15,000 units.
4. Famotidine (20 mg) Film-Coated Tablets. The required quantity is 13,300 units.
5. Dexamethasone (4 mg/ ml) Solution for Injections. The required quantity is 33,300 units.
6. Sevelamer (800 mg) Film-Coated Tablets. The required quantity is 22,320 units.
7. Dipyridamole (25 mg) Coated Tablets. The required quantity is 21,000 units.

Reply

25 Jan 2022

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA12421]

Multiprofile Hospital for Active Treatment - Ivan Skenderov Eood is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 10-Feb-2022.
1. Sodium Chloride (9 g/ l in 500 ml) Solution for Infusions. The required quantity is 23,500 units.
2. Dexamethasone (4 mg/ ml in 1 ml) Solution for Injections. The required quantity is 33,300 units.
3. Ceftriaxone (2 g) Powder for Injections. The required quantity is 30,000 units.
4. Bromhexine (8 mg) Tablets. The required quantity is 15,000 units.
5. Sevelamer (800 mg) Film-coated Tablets. The required quantity is 22,320 units.

Reply

15 Jan 2022

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA09837]

Multi-profile hospital for active treatment "Dr Stoycho Hristov" EOOD is looking for supplies of Various Finished Dosage Formulations. The deadline is 29-March-2021.
1. Bromhexine (8 mg and 2mg/ ml in 2 ml) Tablets. The required quantity is 10,000 units and 4,000 units respectively.
2. Ambroxol (5 mg/ 5 ml in 100 ml, 30 mg/ 5 ml in 150 ml, 15 mg/ 5 ml in 120 ml and 30 mg/ 5 ml in 120 ml) Oral Solution. The required quantity is 1,000 units, 1,500 units, 1,000 units and 2,000 units respectively.
3. Chloropyramine (10 mg/ ml in 2 ml) Injection. The required quantity is 300 units.
4. Promethazine Hydrochloride (25 mg/ ml in 2 ml) Injection. The required quantity is 100 units.
5. Dimenhydrinate (50 mg) Tablets. The required quantity is 1,500 units.
6. Sevelamer (800 mg x 180 pcs) Tablets. The required quantity is 10,800 units.
7. Desloratadine (5 mg) Tablets. The required quantity is 150 units.
8. Iopamidol (370 mg/ ml in 50 ml) Solution for Injection. The required quantity is 100 units.
9. Montelukast (10 mg) Tablets. The required quantity is 900 units.
10. Dimenhydrinate (40 mg) Supplement. The required quantity is 300 units.

Reply

01 Mar 2021

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA09797]

Multi-profile hospital for active treatment - Shumen "AD" is looking for supplies of Various Finished Dosage Formulations. The deadline is 22-March-2021.
1. Bromhexine Hydrochloride (2 mg/ ml in 2 ml and 4 mg/ 5 ml in 125 ml) Solution for Injection. The required quantity is 72,000 units and 10 units respectively.
2. Chloropyramine Hydrochloride (10 mg/ ml in 2 ml) Solution for Injection. The required quantity is 7,500 units.
3. Barium Sulfate (90 g x 1) Powder. The required quantity is 470 units.
4. Ciprofloxacin (3 mg/ ml in 5 ml) Ear/ Eye Drops Solution. The required quantity is 170 units.
5. Sevelamer Hydrochloride (800 mg x 180) Film-Coated Tablets. The required quantity is 180 units.
6. Iopamidol (755,3 mg/ ml in 50 ml) Solution for Injection. The required quantity is 2,000 units.
7. Levocetirizine Dihydrochloride (5 mg/ ml in 20 ml) Oral Drops. The required quantity is 400 units.
8. Proxymetacaine Hydrochloride (5 mg/ ml in 15 ml) Eye Drops Solution. The required quantity is 100 units.
9. Tropicamide (10 mg/ ml in 10 ml) Eye Drops Solution. The required quantity is 55 units.
10. Desloratadine (5 mg x 20) Tablets. The required quantity is 50 units.

Reply

23 Feb 2021

Enquiry//eCTD Dossiers required for various products [ENA00027]

Bilcare, a reliable and credible long-term partner of the global pharmaceutical industry for Clinical Trial Material Supplies has received requests for the following products -
1. Colesevalam tablets 625 mg for US market.
2. Nitrofurantoin capsules 50/ 100mg for UK, South Africa, Italy and Croatia markets
3. Cetirizine tablets 20 mg for Canada /Us/EU market
4. Colchicine tablets 0.5 mg for UK market
5. Carbimazole tablets 5 & 20 mg for UK market
6. Tolterodine ER capsule 2/4 mg for US market
7. Sevelamer Carbonate tablets 800 mg for US market
8. Sevelamer suspension for US
9. Carbidopa tablets for EU.
10. Azithromycin 250 mg capsules for EU
11. Mesalamine 1200 mg tabs for EU
12. Mesalazine 400 mg and 800 mg for EU
13. Alimemazine 10mg tab for EU
14. Hydrocortisone 10 mg tab for EU
15. Diclofenac sod.3%, sodium hyaluronate 2.5% (Solaraze) for EU
16. Ciprofibrate 100 mg tab for EU
17. Hydroxy urea capsules for US/EU
18. Tamoxifen citrate tabs for US/EU
19. Gefitinib tabs for US/EU
20. Sunitinib capsules for US/EU
21. Lacosamide for EU
22. Aripiprazole tabs for US
23. Darifenacin ER for US
24. Memantine tablets 5/10mg, Oral solution 2mg/ml, ER capsules 7/14/21/28mg for US,
25. Memantine ER + Donepezil capsules 14mg+10mg/ 28mg+10mg for US

Interested companies should respond immediately to Chhanda Das, VP-QA and Regulatory, Bilcare Limited at Chhanda.Das_GCS@bilcare.com.

Reply

04 Jul 2016